- Home
- AUR vs NBIX Comparison
AUR vs NBIX Comparison
Compare AUR & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUR
- NBIX
- Stock Information
- Founded
- AUR 2017
- NBIX 1992
- Country
- AUR United States
- NBIX United States
- Employees
- AUR N/A
- NBIX N/A
- Industry
- AUR EDP Services
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AUR Technology
- NBIX Health Care
- Exchange
- AUR Nasdaq
- NBIX Nasdaq
- Market Cap
- AUR 10.4B
- NBIX 11.0B
- IPO Year
- AUR N/A
- NBIX 1996
- Fundamental
- Price
- AUR $6.11
- NBIX $101.38
- Analyst Decision
- AUR Buy
- NBIX Strong Buy
- Analyst Count
- AUR 9
- NBIX 21
- Target Price
- AUR $9.13
- NBIX $163.00
- AVG Volume (30 Days)
- AUR 14.1M
- NBIX 1.8M
- Earning Date
- AUR 05-08-2025
- NBIX 05-05-2025
- Dividend Yield
- AUR N/A
- NBIX N/A
- EPS Growth
- AUR N/A
- NBIX 33.20
- EPS
- AUR N/A
- NBIX 3.29
- Revenue
- AUR N/A
- NBIX $2,355,300,000.00
- Revenue This Year
- AUR N/A
- NBIX $15.48
- Revenue Next Year
- AUR $806.09
- NBIX $15.99
- P/E Ratio
- AUR N/A
- NBIX $30.81
- Revenue Growth
- AUR N/A
- NBIX 24.81
- 52 Week Low
- AUR $2.10
- NBIX $84.23
- 52 Week High
- AUR $10.77
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- AUR 45.01
- NBIX 46.65
- Support Level
- AUR $5.76
- NBIX $84.23
- Resistance Level
- AUR $6.54
- NBIX $112.74
- Average True Range (ATR)
- AUR 0.70
- NBIX 5.17
- MACD
- AUR -0.03
- NBIX 0.59
- Stochastic Oscillator
- AUR 48.70
- NBIX 60.45
About AUR Aurora Innovation Inc.
Aurora Innovation Inc is engaged in delivering self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles, and underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, an advanced and scalable suite of self-driving hardware, software and data services designed as a platform to adapt and interoperate amongst vehicle types and applications.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.